Early Neurophysiological Markers of Language Impairments
Recruiting now
Conditions studied: Development, Infant, Development, Language, Developmental Language Disorder, Learning Disabilities
In brief
The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.
Key facts
- Study ID
- NCT05767242
- Run by
- IRCCS Eugenio Medea
- People needed
- 100
- Starts
- 2022-02-21
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-02-05
Who can join
Age: 1 and older, up to 8. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy infants aged <24 months
- Infants with and without familial risk for language impairments (infants are assigned to the group with familial risk if at least one first-degree relative had a certified (clinical) diagnosis of language impairment or learning disability
- Both parents are native-Italian speakers
You may not qualify if…
- Gestational age < 37 weeks and/or birth weight < 2500 grams
- APGAR scores at birth at 1' and 5' < 7
- Bayley Cognitive Score < 7
- Presence of certified diagnosis of intellectual deficiency, attention-deficit disorder, sensorial and neurological disorders, or autism within first-degree relative
Where it is running
- Associazione La Nostra Famiglia - IRCCS Eugenio Medea — Bosisio Parini, LC, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.